Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in CashFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitShares OutstandingShares Outstanding
Ratios

Goldenwell Biotech (GWLL) Shares Issued (2019 - 2021)

Goldenwell Biotech filings provide 3 years of Shares Issued readings, the most recent being $13675.0 for Q3 2021.

  • On a quarterly basis, Shares Issued changed N/A to $13675.0 in Q3 2021 year-over-year; TTM through Jun 2023 was $13675.0, a N/A change, with the full-year FY2022 number at $884700.0, up 862.68% from a year prior.
  • Shares Issued hit $13675.0 in Q3 2021 for Goldenwell Biotech, down from $78225.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $248904.0 in Q4 2019 to a low of $1000.0 in Q4 2020.
  • Median Shares Issued over the past 3 years was $45950.0 (2021), compared with a mean of $71221.5.
  • Biggest five-year swings in Shares Issued: crashed 99.6% in 2020 and later skyrocketed 971.58% in 2021.
  • Goldenwell Biotech's Shares Issued stood at $248904.0 in 2019, then crashed by 99.6% to $1000.0 in 2020, then surged by 1267.5% to $13675.0 in 2021.
  • The last three reported values for Shares Issued were $13675.0 (Q3 2021), $78225.0 (Q2 2021), and $78225.0 (Q1 2021) per Business Quant data.